Cboe UK CHF

Tecan Group AG (TECNZ.XC)

170.50

-0.40

(-0.23%)

As of 11:34:36 AM GMT+1. Market Open.

Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full year 2025

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full year 2025 Männedorf, Switzerland, May 12, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today provided a qualitative update on its performance for the first quarter of 2025.On March 12, 2025, Tecan indicated a decline in sales in local currencies for the first half of the year. In line with expect

GlobeNewswire 2 days ago

TCGGY

TCHBF
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

DURHAM, N.C. & MÄNNEDORF, Switzerland, April 25, 2025--BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of hundreds to thousands of individual cells, addressing growing demand for scalable, multiomics

Business Wire 18 days ago

TCGGY

TCHBF
Tecan reports key outcomes from Annual General Meeting 2025

Tecan reports key outcomes from Annual General Meeting 2025 Stable dividend of CHF 3.00 per shareLukas Braunschweiler, Myra Eskes, Oliver Fetzer, Matthias Gillner, Christa Kreuzburg, Monica Manotas and Daniel R. Marshak re-elected as members of the Board of DirectorsLukas Braunschweiler confirmed by shareholders as Chair of the BoardMyra Eskes, Christa Kreuzburg and Daniel R. Marshak confirmed as members of the Compensation CommitteeShareholders approved the maximum compensation for the Board of

GlobeNewswire last month

TCGGY

TCHBF
Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits

MÄNNEDORF, Switzerland, April 03, 2025--Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The asset purchase includes the manufacturing process of four ELISA kits – two in vitro diagnostic (IVD) products for specialty diagnostics and disease monitoring, and two research-use-only (RUO) kits.

Business Wire last month

TCGGY

TCHBF
Tecan publishes agenda for the Annual General Meeting 2025

Tecan publishes agenda for the Annual General Meeting 2025 Board of Directors will propose the re-election of seven current membersKaren Huebscher will not be standing for re-election Myra Eskes, Christa Kreuzburg and Daniel R. Marshak proposed for re-election to the Compensation CommitteeReport of non-financial matters submitted for approval for the first time with an audit certificateProposal for a stable dividend of CHF 3.00 per share, reflecting solid cash flows and ongoing positive business

GlobeNewswire last month

TCGGY

TCHBF
Tecan Group AG (XSWX:TECN) Full Year 2024 Earnings Call Highlights: Navigating Challenges with ...

Despite a challenging market environment, Tecan Group AG (XSWX:TECN) focuses on innovation, sustainability, and strategic cost management to maintain a strong financial position.

GuruFocus.com 2 months ago

TECN.SW
Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions Financial results for the full year 2024 – Highlights Sales of CHF 934.3 million (2023: CHF 1,074.4 million), down by -13.0% in Swiss francs and by -11.5% in local currencies; H2 sales decrease by -11.3% in local currenciesDecline in sales mainly due to softness in the instrument business with biopharmaceutical

GlobeNewswire 2 months ago

TCGGY

TCHBF
Tecan schedules conference call on March 12 to discuss Full-Year 2024 Financial Results

Tecan schedules conference call on March 12 to discuss Full-Year 2024 Financial Results Männedorf, Switzerland, March 5, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media conference call to discuss the full-year 2024 financial results on Wednesday, March 12, 2025 at 09:00 am CET. The press release with the 2024 full-year financial results and the Annual Report 2024 will be published on March 12, 2025 at 6:00 am CET. The conference call will be audio-webcast with sy

GlobeNewswire 2 months ago

TCGGY

TCHBF
Tecan Introduces Veya: Bringing Digital, Scalable Automation to Labs Worldwide

MÄNNEDORF, Switzerland, January 27, 2025--Tecan, the global leader in laboratory automation, today announced the unveiling of Veya™, a transformative liquid handling platform designed to bring efficiency, precision and compliance to laboratories of all sizes. The platform, showcased at the Society for Laboratory Automation and Screening (SLAS) international conference, San Diego, underscores Tecan’s continued commitment to innovation and the democratization of lab automation.

Business Wire 3 months ago

TCGGY

TCHBF
Tecan meets revised sales outlook for fiscal year 2024

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan meets revised sales outlook for fiscal year 2024 Männedorf, Switzerland, January 8, 2025 – In a trading statement, the Tecan Group (SIX Swiss Exchange: TECN) today published unaudited preliminary sales results for fiscal year 2024, meeting the revised sales outlook provided on October 16, 2024. The year 2024 was marked by a challenging market environment for Tecan. Reduced spending in the biopharmaceuti

GlobeNewswire 4 months ago

TCGGY

TCHBF
Tecan to present at upcoming Investor Conferences

Männedorf, Switzerland, January 6, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend and present at the following investor conferences in the upcoming weeks: Baader Helvea Swiss Equities Conference, Bad Ragaz, SwitzerlandDate: 9 January 2025 Participants: Dr. Achim von Leoprechting, CEO Tania Micki, CFO Martin Brändle, SVP, Corp. Comm. & Investor RelationsNot webcasted. Octavian Seminar 2025, Davos, SwitzerlandDate: 10 January 2025Participants: Dr. Achim von L

GlobeNewswire 4 months ago

TCGGY

TCHBF
Tecan’s Capital Markets Day highlights strategic growth drivers, groundbreaking innovation and product launches

Tecan’s Capital Markets Day highlights strategic growth drivers, groundbreaking innovation and product launches Männedorf, Switzerland, October 22, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) is hosting a Capital Markets Day, including a live webcast, today in Männedorf, Switzerland, providing investors with an in-depth view of the company’s solid foundations for continued growth and profitability improvements. The strategic growth drivers that enable the company to capitalize on industry

GlobeNewswire 6 months ago

TCGGY

TCHBF
Tecan provides update on current trading and revised outlook for full year 2024

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan provides update on current trading and revised outlook for full year 2024 Substantial reductions in OEM customer forecasts as the main factor negatively impacting outlook for 2024 since last update in AugustLife Sciences Business continues to face a challenging market environment but is showing sequential growth in the second half of 2024Rigorous cost-down program being executedPositive mid-term outlook

GlobeNewswire 6 months ago

TCGGY

TCHBF
Tecan crashes 15% after slashing sales forecast

Shares of Tecan (SIX:TECN) crashed on Tuesday after the company slashed its sales forecasts for 2024, citing a challenging first half of the year marked by declines in key financial metrics. The revised outlook came as Tecan grappled with weaker-than-expected demand across several critical markets. Tecan plunged 16.2% to CHF 273.60 at 4:50 AM (0850 GMT).

Investing.com 8 months ago

TECN.SW
Tecan reports financial results for the first half of 2024 and revises its outlook for full year 2024

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports financial results for the first half of 2024 and revises its outlook for full year 2024 Financial results for the first half of 2024 – Highlights Sales of CHF 467.2 million (H1 2023: CHF 541.5 million) Sales development of -11.6% in local currencies or -13.7% in Swiss francsDecline in sales mainly due to softness in the instrument business with biopharmaceutical companies globally and general ma

GlobeNewswire 8 months ago

TCGGY

TCHBF
Tecan schedules conference call on August 13th to discuss half year 2024 financial results

Tecan schedules conference call on August 13th to discuss half year 2024 financial results Männedorf, Switzerland, August 6, 2024 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2024 on Tuesday, August 13th, 2024 at 08:30 CEST. The results will be published on August 13th, 2024 at 6:00 CEST. The conference call will be audio-webcast with synchronized presentation slides. The webcast and a replay of the webcast w

GlobeNewswire 9 months ago

TCGGY

TCHBF
Tecan appoints Mukta Acharya Head of the Life Sciences Business division

Tecan appoints Mukta Acharya Head of the Life Sciences Business division Männedorf, Switzerland, June 24, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Mukta Acharya, currently serving as President, Tecan Americas, has been appointed the new Head of the Life Sciences Business division and a member of the Management Board of the Tecan Group. She is expected to assume her new position on August 1, 2024. Dr. Klaus Lun, Head of the Life Sciences Business since 2017 and a mem

GlobeNewswire 10 months ago

TCGGY

TCHBF

Performance Overview

Return	TECNZ.XC	MSCI WORLD (^990100-USD-STRD)
YTD	-15.34%	+2.96%
1-Year	-48.18%	+11.93%
3-Year	-31.34%	+41.75%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Tecan Group AG (TECNZ.XC)

Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full year 2025

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

Tecan reports key outcomes from Annual General Meeting 2025

Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits

Tecan publishes agenda for the Annual General Meeting 2025

Tecan Group AG (XSWX:TECN) Full Year 2024 Earnings Call Highlights: Navigating Challenges with ...

Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions

Tecan schedules conference call on March 12 to discuss Full-Year 2024 Financial Results

Tecan Introduces Veya: Bringing Digital, Scalable Automation to Labs Worldwide

Tecan meets revised sales outlook for fiscal year 2024

Tecan to present at upcoming Investor Conferences

Tecan’s Capital Markets Day highlights strategic growth drivers, groundbreaking innovation and product launches

Tecan provides update on current trading and revised outlook for full year 2024

Tecan crashes 15% after slashing sales forecast

Tecan reports financial results for the first half of 2024 and revises its outlook for full year 2024

Tecan schedules conference call on August 13th to discuss half year 2024 financial results

Tecan appoints Mukta Acharya Head of the Life Sciences Business division

Performance Overview